LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY

被引：0

作者：

Howard, James F., Jr. ^{[1
]}

Bril, Vera ^{[2
]}

Tuan Vu ^{[3
]}

Karam, Chafic ^{[4
]}

Peric, Stojan ^{[5
]}

De Bleecker, Jan L. ^{[6
]}

Murai, Hiroyuki ^{[7
]}

Meisel, Andreas ^{[8
,9
]}

Beydoun, Said ^{[10
]}

Pasnoor, Mamatha ^{[11
]}

Guglietta, Antonio ^{[12
]}

T'joen, Caroline ^{[12
]}

Utsugisawa, Kimiaki ^{[13
]}

Verschuuren, Jan ^{[14
]}

Mantegazza, Renato ^{[15
]}

机构：

[1] Univ N Carolina, Chapel Hill, NC 27515 USA

[2] Univ Toronto, Univ Hlth Network, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Toronto, ON, Canada

[3] Univ S Florida, Morsani Coll Med, Tampa, FL USA

[4] Univ Penn, Penn Neurosci Ctr, Philadelphia, PA 19104 USA

[5] Univ Belgrade, Clin Ctr Serbia, Neurol Clin, Belgrade, Serbia

[6] Ghent Univ Hosp, Ghent, Belgium

[7] Int Univ Hlth & Welf, Sch Med, Dept Neurol, Tokyo, Japan

[8] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany

[9] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany

[10] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA

[11] Univ Kansas, Dept Neurol, Med Ctr, Kansas City, KS USA

[12] argenx, Ghent, Belgium

[13] Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Japan

[14] Leiden Univ Med Ctr, Dept Neurol, Leiden, Netherlands

[15] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neuroimmunol & Neuromuscular Dis, Milan, Italy

来源：

MUSCLE & NERVE | 2022年 / 65卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S9 / S10

页数：2

共 50 条

[21] SAFETY AND TOLERABILITY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTEGRATED INTERIM ANALYSIS OF INFECTION RISK AND HEMATOLOGICAL CHANGES
Muppidi, Srikanth
Pasnoor, Mamatha
Gelinas, Deborah
Brauer, Edward
Kerstens, Rene
Bhavaraju-Sanka, Ratna
Howard, James
MUSCLE & NERVE, 2022, 66 : S104 - S104
[22] OBSERVED EFFICACY OF EFGARTIGIMOD IN GENERALIZED MYASTHENIA GRAVIS ACROSS PATIENT SUBGROUPS IN THE ADAPT-SC plus STUDY
Muppidi, Srikanth
Vu, Tuan
Bhavaraju-Sanka, Ratna
Brauer, Eddie
Kerstens, Rene
Utsugisawa, Kimiaki
Meisel, Andreas
MUSCLE & NERVE, 2024, 70 (03) : 703 - 703
[23] Long-term safety and efficacy of eculizumab in generalized myasthenia gravis
Muppidi, Srikanth
Utsugisawa, Kimiaki
Benatar, Michael
Murai, Hiroyuki
Barohn, Richard J.
Illa, Isabel
Jacob, Saiju
Vissing, John
Burns, Ted M.
Kissel, John T.
Nowak, Richard J.
Andersen, Henning
Casasnovas, Carlos
de Bleecker, Jan L.
Vu, Tuan H.
Mantegazza, Renato
O'Brien, Fanny L.
Wang, Jing Jing
Fujita, Kenji P.
Howard, James F., Jr.
Kaya, Angela
Khursigara, Gus
Armstrong, Roisin
Diab, Diaa
Capocelli, Kelley
Lane, Cindy
Sanders, Vicky
Gandolfo, Ruth
MUSCLE & NERVE, 2019, 60 (01) : 14 - 24
[24] TREATMENT OF PATIENTS WITH MYASTHENIA GRAVIS WITH EFGARTIGIMOD: RESULTS OF THE PHASE 3 ADAPT STUDY
Howard, J.
Vu, T.
Bril, V.
Peric, S.
Verschuuren, J.
Mantegazza, R.
Murai, H.
Ulrichts, P.
Guglietta, A.
de Haard, H.
Parys, W.
Beydoun, S.
Pasnoor, M.
Karam, C.
Muppidi, Sr
Bertorini, T.
Bhavaraju-Sanka, R.
Li, Y.
MUSCLE & NERVE, 2020, 62 : S125 - S126
[25] LONG-TERM SAFETY AND EFFICACY OF EFGARTIGIMOD PH20 SC IN GENERALIZED MYASTHENIA GRAVIS: INTERIM ANALYSIS OF ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY SERONEGATIVE PARTICIPANTS IN ADAPT-SC
Bhavaraju-Sanka, Ratna
Howard, James F., Jr.
Vu, Tuan
De Bleecker, Jan L.
Utsugisawa, Kimiaki
Pasnoor, Mamatha
Sacca, Francesco
Korobko, Denis
Steeland, Sophie
Noukens, Jan
Van Hoorick, Benjamin
Liu, Li
Podhorna, Jana
Meisel, Andreas
Mantegazza, Renato
MUSCLE & NERVE, 2024, 70 (03) : 516 - 517
[26] Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients
Wang, Pan
Zhang, Bo
Yin, Jian
Xi, Jianying
Tan, Ying
Gao, Feng
Zeng, Fan
Chang, Ting
Zhou, Hao
Liang, Hui
Zhao, Zhongyan
Yang, Huan
Zhao, Chongbo
Huang, Shixiong
FRONTIERS IN NEUROLOGY, 2024, 15
[27] Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC plus )
Howard Jr, James F.
Vu, Tuan
Li, George
Korobko, Denis
Smilowski, Marek
Liu, Li
Gistelinck, Fien
Steeland, Sophie
Noukens, Jan
Van Hoorick, Benjamin
Podhorna, Jana
Borgions, Filip
Li, Yuebing
Utsugisawa, Kimiaki
Wiendl, Heinz
De Bleecker, Jan L.
Mantegazza, Renato
NEUROTHERAPEUTICS, 2024, 21 (05)
[28] Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial
Howard, James F. Jr Jr
Bril, Vera
Vu, Tuan
Karam, Chafic
Perk, Stojan
Margania, Temur
Murai, Hiroyuki
Bilinska, Malgorzata
Shakarishvili, Roman
Smilowski, Marek
Guglietta, Antonio
Ulrichts, Peter
Vangeneugden, Tony
Utsugisawa, Kimiaki
Verschuuren, Jan
Mantegazza, Renato
LANCET NEUROLOGY, 2021, 20 (07): : 526 - 536
[29] Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis
Kim, Yool-hee
Shin, Ha Young
Kim, Seung Min
YONSEI MEDICAL JOURNAL, 2019, 60 (07) : 633 - 639
[30] Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study
Howard Jr, James F.
Bresch, Saskia
Farmakidis, Constantine
Freimer, Miriam
Genge, Angela
Hewamadduma, Channa
Hinton, John
Hussain, Yessar
Juntas-Morales, Raul
Kaminski, Henry J.
Maniaol, Angelina
Mantegazza, Renato
Masuda, Masayuki
Nowak, Richard J.
Sivakumar, Kumaraswamy
Smilowski, Marek
Utsugisawa, Kimiaki
Vu, Tuan
Weiss, Michael D.
Zajda, Malgorzata
Bloemers, Jos
Boroojerdi, Babak
Brock, Melissa
de la Borderie, Guillemette
Duda, Petra W.
Vanderkelen, Mark
Leite, M. Isabel
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17

← 1 2 3 4 5 →